Adamis’ Phase II/III Covid-19 therapy trial fails to meet primary endpoint
Due to a lack of efficacy, the independent Data Safety Monitoring Board advised halting the trial early.
Covid-19
Latest in
Covid-19
Moat reports initial Phase I data for intranasal Covid-19 vaccine
Moat has opened a financing round, with lead investor Cortado Ventures making the initial investment.
Omeros reports clinical data from I-SPY COVID Trial of narsoplimab
According to the trial findings, narsoplimab lowered the risk of mortality in study participants.
eFFECTOR doses first subject in Phase Ib trial of zotatifin for Covid-19
The move to carry out dose escalation follows a positive recommendation from the independent data safety monitoring board.
Pardes initiates Phase II trial of Covid-19 antiviral drug
The company plans to report initial data from this trial in the first quarter of next year.
YishengBio obtains UAE, Philippines approvals for Covid-19 vaccine trials
The recombinant vaccine has potential prophylactic and therapeutic benefits against the Covid-19 infection.
ACP and partners to launch Covid-19 vaccine study for multiple sclerosis
The impact of the number and timing of the vaccine doses on antibody levels and duration in MS patients is…
Kinarus doses first subject in Phase II Covid-19 drug combination trial
The trial will assess the safety, efficacy, and pharmacokinetic profile of KIN001 in participants.